David‐Dan Nguyen
University of Toronto, McGill University, University Health Network
Papers
13
Total Citations
235
H-Index
9
About
David-Dan Nguyen is a urological surgeon and researcher whose work centers on minimally invasive surgical treatment of benign prostatic hyperplasia (BPH), robotic-assisted urological oncology, and patient-centered decision-making. With over 215 citations across his most recognized publications, Nguyen has established himself as a leading voice in advancing and evaluating novel ablative therapies for BPH, including Aquablation, Rezūm, and transperineal laser ablation — areas where his 2023 review has rapidly become a key reference with 58 citations. His contributions to Aquablation research are particularly notable, including a pivotal two-year comparative update of the WATER and WATER II trials that addressed the critical challenge of treating large-volume prostates exceeding 80 cm³. Beyond surgical technique, Nguyen has championed patient empowerment by developing and validating online decision aids to help patients navigate the increasingly complex landscape of BPH surgical options. His work also spans robotic-assisted radical prostatectomy outcomes in elderly men, testosterone replacement therapy safety in prostate cancer patients, and single-port versus multiport partial nephrectomy — demonstrating a broad and clinically impactful research portfolio that bridges innovation, outcomes research, and patient-centered urological care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10